Company intelligence / Profile preview

Blackfrog Technologies

Manipal (headquarters location per company’s local reporting), Karnataka, India

Ownership: Private
Employees: ~44
Development stage: Other

Overview

Blackfrog Technologies’ flagship product, Emvólio, is in commercial use, with notable deployments including rural hospitals for the safe last-mile transport of vaccines; it is WHO-PQS prequalified and has regulatory clearance for manufacture and sale in India[3][4].

Therapeutic areas: HematologyInfectious DiseasesOtherEndocrinology
Modalities: Device
Industry: Consumable Medical Devices

Partnerships

WHO (prequalification)Indian health agencies and immunization initiatives[1]Multiple healthcare and impact investors (including Venture Centre – NCL Pune, BIRAC, Social Alpha, CCAMP, Forge)[1]

Beyond the preview

Go deeper on Blackfrog Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blackfrog Technologies.

Explore the full profile